• Explore /
  • Poster
  • / HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort.

HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort.

Abstract Poster

Authors

null

Mingxi Lin

Fudan University Shanghai Cancer Center, Shanghai, China

Mingxi Lin , Ting Luo , Hui Zhang , Xichun Hu , Wentao Yang , Jian Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1021)

DOI

10.1200/JCO.2023.41.16_suppl.1021

Abstract #

1021

Poster Bd #

242

Abstract Disclosures

Similar Posters

First Author: Xiao Yang

First Author: Aki Morikawa

Poster

2023 ASCO Annual Meeting

Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival.

Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival.

First Author: Hope S. Rugo

First Author: Ji-Yeon Kim